TAK Dividend History & Analysis | 3.8% Yield
TAK has a dividend yield of 3.8% and paid 0.71 USD per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| SUPN NASDAQ Supernus Pharmaceuticals |
1,523 M | 28.68% | 67.38% |
| BMY NYSE Bristol-Myers Squibb |
127,020 M | 4.38% | 5.22% |
| TAK NYSE Takeda Pharmaceutical |
67,157 M | 3.83% | 6.03% |
| NVS NYSE Novartis |
305,825 M | 3.06% | 6.98% |
| GSK NYSE GSK |
100,885 M | 3.53% | 5.13% |
| NOVN SW Novartis |
309,130 M | 2.99% | 6.19% |
| VTRS NASDAQ Viatris |
21,789 M | 3.50% | 4.20% |
| MRK NYSE Merck |
362,526 M | 2.89% | 4.72% |
| ORNBV HE Orion |
16,067 M | 2.38% | 5.57% |
| HLUN-B CO H Lundbeck |
8,233 M | 3.08% | 3.50% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLUN-B CO H Lundbeck |
8,233 M | 26.64% | 100.0% |
| SECT-B ST Sectra (publ) |
6,295 M | 26.84% | 99.0% |
| FAGR BR Fagron |
1,993 M | 18.76% | 100.0% |
| LLY NYSE Eli Lilly |
1,215,626 M | 15.25% | 100.0% |
| TUB BR Tubize-Fin |
12,288 M | 9.60% | 100.0% |
| NVS NYSE Novartis |
305,825 M | 8.79% | 100.0% |
| MRK NYSE Merck |
362,526 M | 5.34% | 100.0% |
| RPRX NASDAQ Royalty Pharma |
39,044 M | 5.31% | 100.0% |
| IPN PA Ipsen |
14,410 M | 7.55% | 98.0% |
| JNJ NYSE Johnson & Johnson |
664,947 M | 4.72% | 100.0% |
TAK Dividend History
Dividend Monthly Return EX date, 4.7 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
| EX-DATE | RECORD | PAYMENT | PERIOD | DIV/SHARE | GROWTH | PAYOUT YIELD |
|---|---|---|---|---|---|---|
| 2026-09-29 | 2026-09-30 | 0.397 | +28.8% | 2.14% | ||
| 2026-03-31 | 2026-03-31 | 2026-07-06 | Semiannual | 0.3083 | -4.3% | 1.69% |
| 2025-09-30 | 2025-09-30 | 2025-12-11 | Semiannual | 0.3221 | -5% | 2.23% |
| 2025-03-31 | 2025-03-31 | 2025-07-07 | Semiannual | 0.339 | +1.8% | 2.28% |
| 2024-09-30 | 2024-09-30 | 2024-12-12 | Semiannual | 0.333 | +10.8% | 2.31% |
| 2024-03-27 | 2024-03-28 | 2024-07-08 | Semiannual | 0.3006 | -5.8% | 2.09% |
| 2023-09-28 | 2023-09-29 | 2023-12-11 | Semiannual | 0.3191 | +2.9% | 2.06% |
| 2023-03-30 | 2023-03-31 | 2023-07-10 | Semiannual | 0.31 | +2.9% | 1.9% |
| 2022-09-29 | 2022-09-30 | 2022-12-12 | Semiannual | 0.3012 | +9.5% | 2.31% |
| 2022-03-30 | 2022-03-31 | 2022-07-11 | Semiannual | 0.2752 | 0% | 1.89% |
TAK Dividend FAQ
As of November 2026, TAK's dividend yield is 3.83%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of 0.71 USD by the current share price of 20.93.
As of November 2026, TAK paid a dividend of 0.71 USD in the last 12 months. The last dividend was paid on 2026-09-29 and the payout was 0.397 USD.
TAK pays dividends semi-annually. Over the last 12 months, TAK has issued 2 dividend payments. The last dividend payment was made on 2026-09-29.
Based on historical data, the forecasted dividends per share for TAK for the next payments are between 0.349 (-12.1%) and 0.382 (-3.8%). This indicates a moderate dividend reduction compared to the last payment. The expected Yield for the next 12 months is about 3.49%.
The latest dividend paid per share was 0.397 USD with an Ex-Dividend Date of 2026-09-29. The next Ex-Dividend date for Takeda Pharmaceutical (TAK) is currently unknown.
The next Ex-Dividend date for Takeda Pharmaceutical (TAK) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
TAK's average dividend growth rate over the past 5 years is 3.66% per year. Strong growth: TAK's dividend growth is outpacing inflation.
TAK's 5-Year Yield on Cost is 6.03%. If you bought TAK's shares at 11.70 USD five years ago, your current annual dividend income (0.71 USD per share, trailing 12 months) equals 6.03% of your original purchase price.
TAK Payout Consistency is 100.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number. Very consistent: Takeda Pharmaceutical has a strong track record of consistent dividend payments over its lifetime.
TAK's 3.83% Dividend Yield is considered as moderate. This is usually a sign of a value company.
The Dividend Payout Ratio of TAK is 1.5%. Very low - Often a strong indicator of potential dividend growth.
TAK's Overall Dividend Rating is 57.87%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
TAK Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-11-03 02:38 UTC